(primary solid tumor cohort)
This pipeline computes the correlation between significant arm-level copy number variations (cnvs) and selected clinical features.
Testing the association between copy number variation 58 arm-level results and 8 clinical features across 104 patients, 8 significant findings detected with Q value < 0.25.
-
1q gain cnv correlated to 'Time to Death'.
-
6q gain cnv correlated to 'Time to Death'.
-
7p gain cnv correlated to 'TUMOR.STAGE'.
-
17p gain cnv correlated to 'PATHOLOGY.T' and 'TUMOR.STAGE'.
-
3q loss cnv correlated to 'Time to Death'.
-
5p loss cnv correlated to 'Time to Death'.
-
17p loss cnv correlated to 'Time to Death'.
Table 1. Get Full Table Overview of the association between significant copy number variation of 58 arm-level results and 8 clinical features. Shown in the table are P values (Q values). Thresholded by Q value < 0.25, 8 significant findings detected.
|
Clinical Features |
Time to Death |
AGE | GENDER |
KARNOFSKY PERFORMANCE SCORE |
PATHOLOGY T |
PATHOLOGY N |
PATHOLOGICSPREAD(M) |
TUMOR STAGE |
||
| nCNV (%) | nWild-Type | logrank test | t-test | Fisher's exact test | t-test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | |
| 17p gain | 52 (50%) | 52 |
0.231 (1.00) |
0.0507 (1.00) |
0.0208 (1.00) |
0.182 (1.00) |
0.000295 (0.119) |
0.216 (1.00) |
0.0613 (1.00) |
0.000279 (0.113) |
| 1q gain | 8 (8%) | 96 |
8.75e-05 (0.0356) |
0.801 (1.00) |
0.433 (1.00) |
0.00346 (1.00) |
0.836 (1.00) |
0.0794 (1.00) |
0.00604 (1.00) |
|
| 6q gain | 3 (3%) | 101 |
4.2e-06 (0.00171) |
0.26 (1.00) |
0.549 (1.00) |
0.531 (1.00) |
0.00657 (1.00) |
0.0498 (1.00) |
||
| 7p gain | 55 (53%) | 49 |
0.0751 (1.00) |
0.949 (1.00) |
0.0587 (1.00) |
0.184 (1.00) |
0.00153 (0.617) |
0.396 (1.00) |
0.16 (1.00) |
0.000465 (0.188) |
| 3q loss | 3 (3%) | 101 |
2.4e-06 (0.00098) |
0.325 (1.00) |
1 (1.00) |
0.0705 (1.00) |
0.681 (1.00) |
0.203 (1.00) |
0.0994 (1.00) |
|
| 5p loss | 4 (4%) | 100 |
0.000193 (0.0782) |
0.0662 (1.00) |
0.101 (1.00) |
0.0147 (1.00) |
0.0952 (1.00) |
0.628 (1.00) |
0.0994 (1.00) |
|
| 17p loss | 5 (5%) | 99 |
1.56e-07 (6.39e-05) |
0.491 (1.00) |
0.0383 (1.00) |
0.149 (1.00) |
0.336 (1.00) |
0.0931 (1.00) |
0.0423 (1.00) |
|
| 2p gain | 11 (11%) | 93 |
0.186 (1.00) |
0.357 (1.00) |
0.747 (1.00) |
0.541 (1.00) |
0.808 (1.00) |
0.4 (1.00) |
0.0441 (1.00) |
0.0342 (1.00) |
| 2q gain | 13 (12%) | 91 |
0.342 (1.00) |
0.847 (1.00) |
0.753 (1.00) |
0.501 (1.00) |
0.917 (1.00) |
0.0554 (1.00) |
0.0624 (1.00) |
0.00852 (1.00) |
| 3p gain | 24 (23%) | 80 |
0.42 (1.00) |
0.92 (1.00) |
0.0815 (1.00) |
0.0792 (1.00) |
0.0156 (1.00) |
1 (1.00) |
0.692 (1.00) |
0.236 (1.00) |
| 3q gain | 26 (25%) | 78 |
0.293 (1.00) |
0.859 (1.00) |
0.0322 (1.00) |
0.197 (1.00) |
0.0405 (1.00) |
1 (1.00) |
0.766 (1.00) |
0.399 (1.00) |
| 4p gain | 4 (4%) | 100 |
0.0677 (1.00) |
0.0422 (1.00) |
1 (1.00) |
0.255 (1.00) |
0.336 (1.00) |
0.0293 (1.00) |
0.0498 (1.00) |
|
| 4q gain | 3 (3%) | 101 |
0.696 (1.00) |
0.0416 (1.00) |
1 (1.00) |
0.363 (1.00) |
||||
| 5p gain | 10 (10%) | 94 |
0.754 (1.00) |
0.382 (1.00) |
0.725 (1.00) |
0.397 (1.00) |
0.117 (1.00) |
0.646 (1.00) |
0.392 (1.00) |
0.176 (1.00) |
| 5q gain | 10 (10%) | 94 |
0.302 (1.00) |
0.612 (1.00) |
0.725 (1.00) |
0.397 (1.00) |
0.401 (1.00) |
0.646 (1.00) |
0.583 (1.00) |
0.404 (1.00) |
| 6p gain | 4 (4%) | 100 |
0.0735 (1.00) |
0.365 (1.00) |
0.301 (1.00) |
0.168 (1.00) |
0.681 (1.00) |
0.00676 (1.00) |
0.0762 (1.00) |
|
| 7q gain | 56 (54%) | 48 |
0.0751 (1.00) |
0.949 (1.00) |
0.0938 (1.00) |
0.184 (1.00) |
0.00379 (1.00) |
0.396 (1.00) |
0.172 (1.00) |
0.00172 (0.689) |
| 8p gain | 5 (5%) | 99 |
0.568 (1.00) |
0.241 (1.00) |
0.661 (1.00) |
0.0523 (1.00) |
0.555 (1.00) |
0.73 (1.00) |
0.16 (1.00) |
|
| 8q gain | 7 (7%) | 97 |
0.00461 (1.00) |
0.621 (1.00) |
0.68 (1.00) |
0.00967 (1.00) |
0.161 (1.00) |
0.483 (1.00) |
0.00872 (1.00) |
|
| 10p gain | 4 (4%) | 100 |
0.489 (1.00) |
0.801 (1.00) |
1 (1.00) |
0.589 (1.00) |
1 (1.00) |
|||
| 10q gain | 3 (3%) | 101 |
0.489 (1.00) |
0.801 (1.00) |
0.549 (1.00) |
0.226 (1.00) |
||||
| 12p gain | 31 (30%) | 73 |
0.979 (1.00) |
0.658 (1.00) |
0.0225 (1.00) |
0.248 (1.00) |
0.953 (1.00) |
0.472 (1.00) |
0.321 (1.00) |
0.347 (1.00) |
| 12q gain | 31 (30%) | 73 |
0.979 (1.00) |
0.658 (1.00) |
0.0225 (1.00) |
0.248 (1.00) |
0.953 (1.00) |
0.472 (1.00) |
0.321 (1.00) |
0.347 (1.00) |
| 13q gain | 11 (11%) | 93 |
0.722 (1.00) |
0.237 (1.00) |
0.747 (1.00) |
0.197 (1.00) |
0.602 (1.00) |
1 (1.00) |
0.74 (1.00) |
|
| 16p gain | 44 (42%) | 60 |
0.55 (1.00) |
0.438 (1.00) |
0.0106 (1.00) |
0.529 (1.00) |
0.961 (1.00) |
0.198 (1.00) |
0.735 (1.00) |
0.861 (1.00) |
| 16q gain | 41 (39%) | 63 |
0.107 (1.00) |
0.55 (1.00) |
0.0317 (1.00) |
0.25 (1.00) |
0.63 (1.00) |
0.183 (1.00) |
0.269 (1.00) |
0.819 (1.00) |
| 17q gain | 62 (60%) | 42 |
0.791 (1.00) |
0.103 (1.00) |
0.203 (1.00) |
0.561 (1.00) |
0.105 (1.00) |
0.149 (1.00) |
0.127 (1.00) |
0.134 (1.00) |
| 18p gain | 6 (6%) | 98 |
0.19 (1.00) |
0.598 (1.00) |
0.661 (1.00) |
0.541 (1.00) |
0.852 (1.00) |
0.28 (1.00) |
0.458 (1.00) |
|
| 18q gain | 4 (4%) | 100 |
0.612 (1.00) |
0.572 (1.00) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
||
| 20p gain | 31 (30%) | 73 |
0.446 (1.00) |
0.0192 (1.00) |
0.654 (1.00) |
0.636 (1.00) |
0.231 (1.00) |
0.859 (1.00) |
0.394 (1.00) |
0.439 (1.00) |
| 20q gain | 32 (31%) | 72 |
0.446 (1.00) |
0.046 (1.00) |
0.651 (1.00) |
0.636 (1.00) |
0.354 (1.00) |
0.859 (1.00) |
0.7 (1.00) |
0.637 (1.00) |
| Xq gain | 4 (4%) | 100 |
0.413 (1.00) |
0.362 (1.00) |
0.101 (1.00) |
0.779 (1.00) |
0.628 (1.00) |
0.356 (1.00) |
||
| 1p loss | 11 (11%) | 93 |
0.727 (1.00) |
0.414 (1.00) |
1 (1.00) |
0.342 (1.00) |
1 (1.00) |
1 (1.00) |
0.539 (1.00) |
|
| 1q loss | 6 (6%) | 98 |
0.649 (1.00) |
0.825 (1.00) |
1 (1.00) |
0.342 (1.00) |
0.713 (1.00) |
0.534 (1.00) |
0.643 (1.00) |
|
| 3p loss | 6 (6%) | 98 |
0.207 (1.00) |
0.0519 (1.00) |
0.661 (1.00) |
0.0754 (1.00) |
0.681 (1.00) |
0.339 (1.00) |
0.0927 (1.00) |
|
| 4p loss | 8 (8%) | 96 |
0.187 (1.00) |
0.104 (1.00) |
0.0141 (1.00) |
0.13 (1.00) |
0.368 (1.00) |
0.352 (1.00) |
0.051 (1.00) |
|
| 4q loss | 9 (9%) | 95 |
0.8 (1.00) |
0.414 (1.00) |
0.0557 (1.00) |
0.2 (1.00) |
0.768 (1.00) |
0.685 (1.00) |
0.14 (1.00) |
|
| 5q loss | 4 (4%) | 100 |
0.0264 (1.00) |
0.23 (1.00) |
0.101 (1.00) |
0.168 (1.00) |
0.628 (1.00) |
0.565 (1.00) |
||
| 6p loss | 9 (9%) | 95 |
0.0291 (1.00) |
0.997 (1.00) |
0.47 (1.00) |
0.248 (1.00) |
0.273 (1.00) |
0.202 (1.00) |
1 (1.00) |
0.335 (1.00) |
| 6q loss | 10 (10%) | 94 |
0.273 (1.00) |
0.361 (1.00) |
0.0756 (1.00) |
0.383 (1.00) |
0.135 (1.00) |
0.228 (1.00) |
0.487 (1.00) |
0.483 (1.00) |
| 8p loss | 3 (3%) | 101 |
0.75 (1.00) |
0.404 (1.00) |
0.0329 (1.00) |
0.226 (1.00) |
1 (1.00) |
0.268 (1.00) |
||
| 9p loss | 13 (12%) | 91 |
0.0801 (1.00) |
0.475 (1.00) |
0.00846 (1.00) |
0.398 (1.00) |
0.0505 (1.00) |
0.597 (1.00) |
0.389 (1.00) |
0.176 (1.00) |
| 9q loss | 13 (12%) | 91 |
0.127 (1.00) |
0.448 (1.00) |
0.0264 (1.00) |
0.398 (1.00) |
0.0383 (1.00) |
0.597 (1.00) |
0.578 (1.00) |
0.295 (1.00) |
| 10p loss | 6 (6%) | 98 |
0.256 (1.00) |
0.987 (1.00) |
0.39 (1.00) |
0.397 (1.00) |
0.382 (1.00) |
0.0583 (1.00) |
0.0931 (1.00) |
0.567 (1.00) |
| 10q loss | 6 (6%) | 98 |
0.0212 (1.00) |
0.666 (1.00) |
1 (1.00) |
0.397 (1.00) |
0.208 (1.00) |
0.151 (1.00) |
0.184 (1.00) |
0.378 (1.00) |
| 11p loss | 8 (8%) | 96 |
0.00469 (1.00) |
0.0515 (1.00) |
0.714 (1.00) |
0.315 (1.00) |
0.527 (1.00) |
0.174 (1.00) |
||
| 11q loss | 9 (9%) | 95 |
0.0212 (1.00) |
0.0668 (1.00) |
1 (1.00) |
0.0534 (1.00) |
0.555 (1.00) |
0.583 (1.00) |
0.0641 (1.00) |
|
| 13q loss | 9 (9%) | 95 |
0.0238 (1.00) |
0.428 (1.00) |
0.00521 (1.00) |
0.2 (1.00) |
0.501 (1.00) |
0.685 (1.00) |
0.283 (1.00) |
|
| 14q loss | 19 (18%) | 85 |
0.925 (1.00) |
0.379 (1.00) |
0.418 (1.00) |
0.377 (1.00) |
0.715 (1.00) |
0.472 (1.00) |
0.24 (1.00) |
0.421 (1.00) |
| 15q loss | 10 (10%) | 94 |
0.0623 (1.00) |
0.366 (1.00) |
0.725 (1.00) |
0.654 (1.00) |
0.135 (1.00) |
1 (1.00) |
0.841 (1.00) |
0.237 (1.00) |
| 16q loss | 3 (3%) | 101 |
0.0329 (1.00) |
0.531 (1.00) |
0.628 (1.00) |
0.356 (1.00) |
||||
| 18p loss | 15 (14%) | 89 |
0.00201 (0.805) |
0.86 (1.00) |
1 (1.00) |
0.342 (1.00) |
0.108 (1.00) |
0.338 (1.00) |
0.789 (1.00) |
0.276 (1.00) |
| 18q loss | 16 (15%) | 88 |
0.00201 (0.805) |
0.86 (1.00) |
0.773 (1.00) |
0.342 (1.00) |
0.0543 (1.00) |
0.338 (1.00) |
0.803 (1.00) |
0.138 (1.00) |
| 19p loss | 4 (4%) | 100 |
0.649 (1.00) |
0.582 (1.00) |
1 (1.00) |
0.589 (1.00) |
0.628 (1.00) |
0.268 (1.00) |
||
| 19q loss | 3 (3%) | 101 |
0.75 (1.00) |
0.877 (1.00) |
1 (1.00) |
0.363 (1.00) |
||||
| 21q loss | 11 (11%) | 93 |
0.152 (1.00) |
0.432 (1.00) |
0.497 (1.00) |
0.665 (1.00) |
1 (1.00) |
1 (1.00) |
0.237 (1.00) |
|
| 22q loss | 20 (19%) | 84 |
0.752 (1.00) |
0.699 (1.00) |
0.109 (1.00) |
0.445 (1.00) |
0.162 (1.00) |
0.447 (1.00) |
0.192 (1.00) |
0.208 (1.00) |
| Xq loss | 3 (3%) | 101 |
0.75 (1.00) |
0.915 (1.00) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
P value = 8.75e-05 (logrank test), Q value = 0.036
Table S1. Gene #1: '1q gain mutation analysis' versus Clinical Feature #1: 'Time to Death'
| nPatients | nDeath | Duration Range (Median), Month | |
|---|---|---|---|
| ALL | 97 | 14 | 0.0 - 182.7 (13.7) |
| 1Q GAIN MUTATED | 7 | 2 | 0.7 - 25.4 (7.6) |
| 1Q GAIN WILD-TYPE | 90 | 12 | 0.0 - 182.7 (14.6) |
Figure S1. Get High-res Image Gene #1: '1q gain mutation analysis' versus Clinical Feature #1: 'Time to Death'
P value = 4.2e-06 (logrank test), Q value = 0.0017
Table S2. Gene #11: '6q gain mutation analysis' versus Clinical Feature #1: 'Time to Death'
| nPatients | nDeath | Duration Range (Median), Month | |
|---|---|---|---|
| ALL | 97 | 14 | 0.0 - 182.7 (13.7) |
| 6Q GAIN MUTATED | 3 | 2 | 7.9 - 13.6 (9.6) |
| 6Q GAIN WILD-TYPE | 94 | 12 | 0.0 - 182.7 (14.4) |
Figure S2. Get High-res Image Gene #11: '6q gain mutation analysis' versus Clinical Feature #1: 'Time to Death'
P value = 0.000465 (Fisher's exact test), Q value = 0.19
Table S3. Gene #12: '7p gain mutation analysis' versus Clinical Feature #8: 'TUMOR.STAGE'
| nPatients | I | II | III | IV |
|---|---|---|---|---|
| ALL | 53 | 7 | 24 | 9 |
| 7P GAIN MUTATED | 36 | 2 | 5 | 4 |
| 7P GAIN WILD-TYPE | 17 | 5 | 19 | 5 |
Figure S3. Get High-res Image Gene #12: '7p gain mutation analysis' versus Clinical Feature #8: 'TUMOR.STAGE'
P value = 0.000295 (Fisher's exact test), Q value = 0.12
Table S4. Gene #23: '17p gain mutation analysis' versus Clinical Feature #5: 'PATHOLOGY.T'
| nPatients | T1 | T2 | T3+T4 |
|---|---|---|---|
| ALL | 58 | 13 | 33 |
| 17P GAIN MUTATED | 36 | 9 | 7 |
| 17P GAIN WILD-TYPE | 22 | 4 | 26 |
Figure S4. Get High-res Image Gene #23: '17p gain mutation analysis' versus Clinical Feature #5: 'PATHOLOGY.T'
P value = 0.000279 (Fisher's exact test), Q value = 0.11
Table S5. Gene #23: '17p gain mutation analysis' versus Clinical Feature #8: 'TUMOR.STAGE'
| nPatients | I | II | III | IV |
|---|---|---|---|---|
| ALL | 53 | 7 | 24 | 9 |
| 17P GAIN MUTATED | 34 | 3 | 4 | 2 |
| 17P GAIN WILD-TYPE | 19 | 4 | 20 | 7 |
Figure S5. Get High-res Image Gene #23: '17p gain mutation analysis' versus Clinical Feature #8: 'TUMOR.STAGE'
P value = 2.4e-06 (logrank test), Q value = 0.00098
Table S6. Gene #33: '3q loss mutation analysis' versus Clinical Feature #1: 'Time to Death'
| nPatients | nDeath | Duration Range (Median), Month | |
|---|---|---|---|
| ALL | 97 | 14 | 0.0 - 182.7 (13.7) |
| 3Q LOSS MUTATED | 3 | 2 | 3.7 - 21.6 (8.8) |
| 3Q LOSS WILD-TYPE | 94 | 12 | 0.0 - 182.7 (13.9) |
Figure S6. Get High-res Image Gene #33: '3q loss mutation analysis' versus Clinical Feature #1: 'Time to Death'
P value = 0.000193 (logrank test), Q value = 0.078
Table S7. Gene #36: '5p loss mutation analysis' versus Clinical Feature #1: 'Time to Death'
| nPatients | nDeath | Duration Range (Median), Month | |
|---|---|---|---|
| ALL | 97 | 14 | 0.0 - 182.7 (13.7) |
| 5P LOSS MUTATED | 4 | 2 | 0.0 - 22.9 (7.4) |
| 5P LOSS WILD-TYPE | 93 | 12 | 0.0 - 182.7 (14.1) |
Figure S7. Get High-res Image Gene #36: '5p loss mutation analysis' versus Clinical Feature #1: 'Time to Death'
P value = 1.56e-07 (logrank test), Q value = 6.4e-05
Table S8. Gene #51: '17p loss mutation analysis' versus Clinical Feature #1: 'Time to Death'
| nPatients | nDeath | Duration Range (Median), Month | |
|---|---|---|---|
| ALL | 97 | 14 | 0.0 - 182.7 (13.7) |
| 17P LOSS MUTATED | 4 | 2 | 0.2 - 11.1 (5.2) |
| 17P LOSS WILD-TYPE | 93 | 12 | 0.0 - 182.7 (14.6) |
Figure S8. Get High-res Image Gene #51: '17p loss mutation analysis' versus Clinical Feature #1: 'Time to Death'
-
Mutation data file = broad_values_by_arm.mutsig.cluster.txt
-
Clinical data file = KIRP-TP.clin.merged.picked.txt
-
Number of patients = 104
-
Number of significantly arm-level cnvs = 58
-
Number of selected clinical features = 8
-
Exclude genes that fewer than K tumors have mutations, K = 3
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For continuous numerical clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the clinical values between tumors with and without gene mutations using 't.test' function in R
For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.